Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Integra Lifesciences Holdings Corp

IART ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Small Cap Analyst: HOLD

Last Close

$16.26

▼ -2.75%

Market Cap $1.26B · Vol 227.21K

Key Metrics

P/E Ratio

N/A

FWD: 6.36

Market Cap

$1.26B

Small Cap

Div Yield

N/A

EPS Growth

+10.20%

YoY

RSI (14)

28.85

Momentum

Beta

1.21

vs Market

52W High

$20.47

20.57% below

52W Low

$8.71

86.68% above

Volume

227.21K

Avg 289.32K

P/B

0.93

Price-to-book

ROE

13.21%

Return on equity

Free Float

85.56%

Public shares

Shariah Compliance8 STANDARDS

✗ Integra Lifesciences Holdings Corp (IART) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does IART pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.90%

-5.74%

-4.01%

+67.11%

YTD

+30.92%

+3.70%

-58.06%

-78.45%

Financials & Valuation

TTM · Annual

Total Revenue	$1.64B
Net Income	$-516,474,000.00
Revenue Growth (YoY)	+0.76%
Gross Margin	55.71%
Operating Margin	11.40%
Net Profit Margin	-31.58%
ROE	13.21%
ROA · ROIC	-14.75% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	6.36
PEG Ratio	N/A
P/S	0.58
P/B	0.93
P/FCF	N/A
EPS Growth	+10.20%
Outstanding Shares	77.77M

Technical Indicators

50-Day SMA	$17.76
200-Day SMA	$13.81
RSI (14)	28.85
Beta	1.21
52-Week High	$20.47
52-Week Low	$8.71

Volume Today	227.21K
Avg Daily Volume (30D)	289.32K
Relative Volume	0.79x
Volatility (10D)	22.45
Volatility (30D)	63.61
Free Float	85.56%

Analyst Consensus

HOLD

Current Price $16.26

Mean Target $19.88

52W Low$8.71 52W High$20.47

Current

Target

$8.71 $20.47

Current Analyst target

+22.23% upside potential · 12 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S7JWM6

ISINUS4579852082

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -2.59% MDT Medtronic PLC -1.89% COR Cencora Inc -1.89% 7741.T Hoya Corp -1.31% BDX Becton Dickinson and Co -3.05%

Company Profile

Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.